Year: 2022

S-82K3_K4_NR_E

ABLIC Launches the S-82K3/K4 Series of 3-serial to 4-serial Cell Secondary Protection ICs with the Industry’s First (*1) Wake-up Function that Allows the Battery to be Connected in Any Order!

Zai-Lab-Limited

Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurrent Adagrasib and Pembrolizumab in First-Line Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Adagrasib in combination with pembrolizumab demonstrates favorable tolerability and promising preliminary efficacy in patients with first-line advanced/metastatic NSCLC harboring a...

Liquidia-Corporation

Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)

Liquidia and Sandoz will collaborate with Mainbridge Health Partners to develop a new infusion pump Liquidia and Sandoz have also...